European Commission approves BALVERSA®▼ (erdafitinib) for
First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial ...
Read more
ADVERTISEMENT
ADVERTISEMENT
Tag: BALVERSA
CHMP adopts positive opinion for BALVERSA® (erdafitinib)
Pending approval, erdafitinib would become the first therapy targeting FGFR3 alterations in patients with metastatic urothelial carcinoma, one of Europe’s ...
Read more
LifeCare News is a registered magazine in RNI (Registrar of Newspapers for India) is started in 2015, as well as Lifecarenews have a malti language portal. Life Care News portal was connected with many reputed news agency.